Midazolam Hydrochloride
16 NDCs across 6 manufacturers|16 Generic,0 Brand
Midazolam Hydrochloride is used to treat anxiety disorders, psychomotor agitation and status epilepticus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 20, 1985, and the first generic was approved Jun 20, 2000.
Midazolam Hydrochloride is available as 16 NDCs from 6 manufacturers (16 generic, 0 brand), with NADAC prices from $0.22 to $1.23 per ML — the most expensive product costs about 5.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Active FDA drug shortage
27 Midazolam Hydrochloride presentations are currently listed in FDA's drug shortage database (first posted Apr 2, 2020). Shortages can move NADAC prices in the following weeks.
Total NDCs
16
16G / 0B
Manufacturers
6
competing in market
Price Spread
$0.22 – $1.23
per ML
7d Activity
avg -0.8% WoW · of 16 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Hospira Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Benzodiazepine class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
6 manufacturers producing MIDAZOLAM HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
MIDAZOLAM HCL 5 MG/ML VIAL | $1.2259 per ML | +0.36% |
MIDAZOLAM HCL 5 MG/ML VIAL | $1.2259 per ML | +0.36% |
MIDAZOLAM HCL 2 MG/ML SYRUP | $0.6177 per ML | -2.88% |
MIDAZOLAM HCL 2 MG/ML SYRUP | $0.6177 per ML | -2.88% |
MIDAZOLAM HCL 10 MG/2 ML VIAL | $0.5652 per ML | -0.34% |
MIDAZOLAM HCL 10 MG/2 ML VIAL | $0.5652 per ML | -0.34% |
MIDAZOLAM HCL 50 MG/10 ML VIAL | $0.4500 per ML | — |
MIDAZOLAM HCL 50 MG/10 ML VIAL | $0.4500 per ML | — |
MIDAZOLAM HCL 2 MG/2 ML VIAL | $0.4200 per ML | — |
MIDAZOLAM HCL 2 MG/2 ML VIAL | $0.4200 per ML | — |
MIDAZOLAM HCL 50 MG/10 ML VIAL | $0.3817 per ML | — |
MIDAZOLAM HCL 50 MG/10 ML VIAL | $0.3817 per ML | — |
MIDAZOLAM HCL 2 MG/2 ML VIAL | $0.2334 per ML | -0.38% |
MIDAZOLAM HCL 2 MG/2 ML VIAL | $0.2334 per ML | -0.38% |
MIDAZOLAM HCL 1 MG/ML VIAL | $0.2185 per ML | — |
MIDAZOLAM HCL 1 MG/ML VIAL | $0.2185 per ML | — |
Frequently Asked Questions
What is Midazolam Hydrochloride used to treat?
Midazolam Hydrochloride is used to treat anxiety disorders, psychomotor agitation and status epilepticus, per the National Library of Medicine's MED-RT classification.
When did Midazolam Hydrochloride become available as a generic?
FDA approved the first generic Midazolam Hydrochloride (ANDA) on Jun 20, 2000.
Is Midazolam Hydrochloride in shortage?
Yes — FDA's drug shortage database currently lists 27 Midazolam Hydrochloride presentations with status "Current", first posted Apr 2, 2020.
How many Midazolam Hydrochloride products are on the market?
The Midazolam Hydrochloride drug market contains 16 NDCs from 6 manufacturers — 16 generic and 0 brand products.
What is the price range for Midazolam Hydrochloride?
NADAC reference prices for Midazolam Hydrochloride range from $0.2185 to $1.2259 per ML — the most expensive product costs about 5.6× the cheapest.
Which manufacturers make Midazolam Hydrochloride?
6 manufacturers list Midazolam Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Hospira Inc. (9), Fresenius Kabi USA, LLC (2), Heritage Pharmaceuticals Inc. (2), Hikma Pharmaceuticals USA Inc. (1), Padagis US LLC (1).
How has the price of Midazolam Hydrochloride changed recently?
Over the past 7 days, 2 Midazolam Hydrochloride NDCs rose and 6 fell, with a market-wide average change of -0.8%.